Biology of Blood and Marrow Transplantation
Volume 12, Issue 4 , Pages 397-407 , April 2006

Graft-versus-Leukemia and Graft-versus-Host Reactions after Donor Lymphocyte Infusion Are Initiated by Host-Type Antigen-Presenting Cells and Regulated by Regulatory T Cells in Early and Long-Term Chimeras

Received 7 July 2005 ,Accepted 30 November 2005.

References 

  1. Kolb HJ , Schmid C , Barrett AJ , Schendel DJ . Graft-versus-leukemia reactions in allogeneic chimeras . Blood . 2004;103:767–776
  2. Johnson BD , Hanke CA , Truitt RL . The graft-versus-leukemia effect of post-transplant donor leukocyte infusion . Leuk Lymphoma . 1996;23:1–9
  3. Dazzi F , Goldman JM . Adoptive immunotherapy following allogeneic bone marrow transplantation . Annu Rev Med . 1998;49:329–340
  4. Porter DL , Antin JH . The graft-versus-leukemia effects of allogeneic cell therapy . Annu Rev Med . 1999;50:369–386
  5. Luznik L , Fuchs EJ . Donor lymphocyte infusions to treat hematological malignancies in relapse after allogeneic blood or marrow transplantation . Cancer Control . 2002;9:123–137
  6. Michalek J , Collins RH , Durrani HP , et al.   Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences . Proc Natl Acad Sci U S A . 2003;100:1180–1184
  7. Patterson AE , Korngold R . Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation . Biol Blood Marrow Transplant . 2001;7:187–196
  8. Kim YM , Sachs T , Asavaroengchai W , Bronson R , Sykes M . Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720 . J Clin Invest . 2003;111:659–669
  9. Amrolia PJ , Muccioli-Casadei G , Yvon E , et al.   Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses . Blood . 2003;102:2292–2299
  10. Weiden PL , Storb R , Tsoi MS , Graham TC , Lerner KG , Thomas ED . Infusion of donor lymphocytes into stable canine radiation chimeras (implications for mechanism of transplantation tolerance) . J Immunol . 1976;116:1212–1219
  11. Johnson BD , Becker EE , LaBelle JL , Truitt RL . Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy . J Immunol . 1999;163:6479–6487
  12. Clark FJ , Chakraverty R . Role of dendritic cells in graft-versus-host disease . J Hematother Stem Cell Res . 2002;11:601–616
  13. Zeiser R , Marks R , Bertz H , Finke J . Immunopathogenesis of acute graft-versus-host disease (implications for novel preventive and therapeutic strategies) . Ann Hematol . 2004;83:551–565
  14. Billiau AD , Fevery S , Rutgeerts O , Landuyt W , Waer M . Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants . Blood . 2002;100:1894–1902
  15. Mapara MY , Kim YM , Wang SP , Bronson R , Sachs DH , Sykes M . Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras (a critical role for host antigen-presenting cells) . Blood . 2002;100:1903–1909
  16. Mapara MY , Kim YM , Marx J , Sykes M . Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen (extinction of graft-versus-leukemia effects after conversion to full donor chimerism) . Transplantation . 2003;76:297–305
  17. Johnson BD , Drobyski WR , Truitt RL . Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease . Bone Marrow Transplant . 1993;11:329–336
  18. Johnson BD , Konkol MC , Truitt RL . CD25+ immunoregulatory T cells of donor origin suppress alloreactivity after BMT . Biol Blood Marrow Transplant . 2002;8:525–535
  19. Xia G , Kovochich M , Truitt RL , Johnson BD . Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent DLI-induced lethal acute GVHD . Biol Blood Marrow Transplant . 2004;10:748–760
  20. Johnson BD , Hanke CA , Becker EE , Truitt RL . Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro . Cell Immunol . 1998;189:149–159
  21. Billiau AD , Fevery S , Rutgeerts O , Landuyt W , Waer M . Transient expansion of Mac1+Ly6G+Ly6C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras (possible implication for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions) . Blood . 2003;102:740–748
  22. Johnson BD , Dagher N , Stankowski WC , Hanke CA , Truitt RL . Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI . Biol Blood Marrow Transplant . 2001;7:589–595
  23. Zhang ZX , Young K , Zhang L . CD3+CD4−CD8− αβ-TCR+ T cell as immune regulatory cell . J Mol Med . 2001;79:419–427
  24. Blazar BR , Lees CJ , Martin PJ , et al.   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions . J Immunol . 2000;165:4901–4909
  25. Shlomchik WD , Couzens MS , Tang CB , et al.   Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells . Science . 1999;285:412–415
  26. Teshima T , Ordermann R , Reddy P , et al.   Acute graft-versus-host disease does not require alloantigen expression on host epithelium . Nat Med . 2002;8:575–581
  27. Bethge WA , Hegenbart U , Stuart MJ , et al.   Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning . Blood . 2004;103:790–795
  28. Georges GE , Storb R , Thompson JD , et al.   Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation . Blood . 2000;95:3262–3269
  29. Van Santen HM , Benoist C , Mathis D . Number of Treg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells . J Exp Med . 2004;200:1221–1230
  30. Taylor PA , Lees C , Blazar BR . The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality . Blood . 2002;99:3493–3499
  31. Hoffmann P , Ermann J , Edinger M , Fathman CG , Strober S . Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation . J Exp Med . 2002;196:389–399
  32. Jones SC , Murphy GF , Korngold R . Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+CD25+ T cells to allow an effective graft-versus-leukemia response . Biol Blood Marrow Transplant . 2003;9:243–256
  33. Edinger M , Hoffmann P , Erman J , et al.   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation . Nat Med . 2003;9:1144–1150
  34. Trenado A , Charlotte F , Fisson S , et al.   Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia . J Clin Invest . 2003;112:1688–1696
  35. North RJ , Bursuker I . Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells . J Exp Med . 1984;159:1295–1311
  36. Sutmuller RP , van Duivenvoorde LM , van Elsas A , et al.   Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses . J Exp Med . 2001;194:823–832
  37. Morse MA , Clay TM , Mosca P , Lyerly HK . Immunoregulatory T cells in cancer immunotherapy . Expert Opin Biol Ther . 2002;2:827–834
  38. Terabe M , Berzofsky JA . Immunoregulatory T cells in tumor immunity . Curr Opin Immunol . 2004;16:157–162
  39. Pelot MR , Pearson DA , Swenson K , et al.   Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen . Biol Blood Marrow Transplant . 1999;5:133–143
  40. Barrett AJ , Mavroudis D , Tisdale J , et al.   T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect . Bone Marrow Transplant . 1998;21:543–551
  41. Verdonck LF , Petersen EJ , Lokhorst HM , et al.   Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation (impact of infused and residual donor T cells) . Bone Marrow Transplant . 1998;22:1057–1063
  42. Marks DI , Lush R , Cavenagh J , et al.   The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation . Blood . 2002;100:3108–3114

PII: S1083-8791(05)01360-1

doi: 10.1016/j.bbmt.2005.11.519

Biology of Blood and Marrow Transplantation
Volume 12, Issue 4 , Pages 397-407 , April 2006

Article Tools

* Image Usage & Resolution